PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sector of biopharmaceuticals, providing promising breakthroughs across numerous health care and industrial apps. With its structural similarity to Obviously derived human serum albumin, OsrHSA gives a safer, much more trusted alternate for therapeutic use, speci